F. Ishikawa, Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region, Nat Biotechnol, vol.25, issue.11, pp.1315-1321, 2007.

D. W. Mcmillin, Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity, Nat Med, vol.16, issue.4, pp.483-489, 2010.

S. W. Lane, D. T. Scadden, and D. G. Gilliland, The leukemic stem cell niche: current concepts and therapeutic opportunities, Blood, vol.114, issue.6, pp.1150-1157, 2009.

M. R. Corces-zimmerman, W. J. Hong, I. L. Weissman, B. C. Medeiros, and R. Majeti, Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission, Proc Natl Acad Sci, vol.111, issue.7, pp.2548-2553, 2014.

L. I. Shlush, Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia, Nature, vol.506, issue.7488, pp.328-333, 2014.

K. Durinck, Novel biological insights in T-cell acute lymphoblastic leukemia, Exp Hematol, vol.43, issue.8, pp.625-639, 2015.

D. Hong, Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia, Science, vol.319, issue.5861, pp.336-339, 2008.

A. A. Ferrando, Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia, Cancer Cell, vol.1, issue.1, pp.75-87, 2002.

P. Van-vlierberghe, R. Pieters, H. B. Beverloo, and J. P. Meijerink, Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia, Br J Haematol, vol.143, issue.2, pp.153-168, 2008.

T. Hoang, Of mice and men: how an oncogene transgresses the limits and predisposes to T cell acute lymphoblastic leukemia, Sci Transl Med, vol.2, issue.21, pp.21-31, 2010.

A. V. Krivtsov, Transformation from committed progenitor to leukaemia stem cell initiated by human cells. BG and TH interpreted the data and wrote the manuscript

, MT's present address is: McGill Cancer Center

, 1 mM PMSF, and a Complete Protease Inhibitor Mixture tablet [Roche]). For immunoprecipitations, cell lysates were incubated with the SCL/TAL1 (C-21) sc-12984 goat polyclonal antibody or with the c-MYC (9E10) sc-40 mouse monoclonal antibody for 2 hours, followed by a 1-hour incubation with protein A-Sepharose CL-4B beads (GE Healthcare), 2× reducing sample buffer (125 mM Tris-HCl, p.4

, The theoretical maximum value for the Z? factor is 1, and ideally the Z? factor is between 0.5 and 1. We performed statistical analyses by Student's t test (*P ? 0.05, **P ? 0.01, ***P ? 0.001). We assumed normality and equal distribution of variance between the different groups analyzed. Survival in mouse experiments was represented with Kaplan-Meier curves, and significance was estimated with log-rank test (GraphPad Prism). Study approval. All AML and T-ALL samples were collected with informed consent according to procedures of the Banque de Cellules Leucémiques du Québec, and the project was approved by the Research Ethics Boards of Maisonneuve-Rosemont Hospital and the University of Montreal, Statistics. Z? value was calculated according to the formula 1 -[3 × (SD of positive control + SD of negative control)/(mean of positive controlmean of negative control)

P. Bg, B. Bg, . Dftv, . Sn, . If et al., JH, JC and GS contributed to experiments with primary MLL-AF9, Nature, vol.442, issue.7104, pp.818-822, 2006.

M. P. Mccormack, The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal, Science, vol.327, issue.5967, pp.879-883, 2010.

A. Cozzio, E. Passegué, P. M. Ayton, H. Karsunky, M. L. Cleary et al., Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors, Genes Dev, vol.17, issue.24, pp.3029-3035, 2003.

B. Gerby, LMO1 and Notch1 reprogram thymocytes into self-renewing cells, PLoS Genet, vol.10, issue.12, p.1004768, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02353324

P. D. Aplan, An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice, EMBO J, vol.16, issue.9, pp.2408-2419, 1997.

M. Tremblay, Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes, Genes Dev, vol.24, issue.11, pp.1093-1105, 2010.

A. P. Weng, Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science, vol.306, issue.5694, pp.269-271, 2004.

W. A. Messersmith, A Phase I, dose-finding study in patients with advanced solid malignancies of the oral ?-secretase inhibitor PF-03084014, Clin Cancer Res, vol.21, issue.1, pp.60-67, 2015.

I. Krop, Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors, J Clin Oncol, vol.30, pp.2307-2313, 2012.

J. H. Van-es, Notch/?-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells, Nature, vol.435, issue.7044, pp.959-963, 2005.

A. P. Weng, c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/ lymphoma, Genes Dev, vol.20, issue.15, pp.2096-2109, 2006.

T. Palomero, NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth, Proc Natl Acad Sci, vol.103, issue.48, pp.18261-18266, 2006.

J. E. Roderick, c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells, Blood, vol.123, issue.7, pp.1040-1050, 2014.

L. Ding, Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing, Nature, vol.481, issue.7382, pp.506-510, 2012.

C. H. Pui, W. L. Carroll, S. Meshinchi, and R. J. Arceci, Biology, risk stratification, and therapy of pediatric acute leukemias: an update, J Clin Oncol, vol.29, issue.5, pp.551-565, 2011.

I. Aifantis, E. Raetz, and S. Buonamici, Molecular pathogenesis of T-cell leukaemia and lymphoma, Nat Rev Immunol, vol.8, issue.5, pp.380-390, 2008.

S. M. Cleveland, Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia, Stem Cells, vol.31, issue.5, pp.882-894, 2013.

B. Gerby, Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations, Leukemia, vol.25, issue.8, pp.1249-1258, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02353642

T. M. Schmitt and J. C. Zúñiga-pflücker, Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro, Immunity, vol.17, issue.6, pp.749-756, 2002.

F. Armstrong, NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity, Blood, vol.113, issue.8, pp.1730-1740, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02353664

U. Koch, ?-Like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment, J Exp Med, vol.205, issue.11, pp.2515-2523, 2008.

M. Mohtashami, D. K. Shah, H. Nakase, K. Kianizad, H. T. Petrie et al., Direct comparison of Dll1-and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes, J Immunol, vol.185, issue.2, pp.867-876, 2010.

S. Herblot, A. M. Steff, P. Hugo, P. D. Aplan, and T. Hoang, SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T ? chain expression, Nat Immunol, vol.1, issue.2, pp.138-144, 2000.

D. S. Chervinsky, X. F. Zhao, D. H. Lam, M. Ellsworth, K. W. Gross et al., Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice, Mol Cell Biol, vol.19, issue.7, pp.5025-5035, 1999.

A. Gutierrez, Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia, J Clin Invest, vol.124, issue.2, pp.644-655, 2014.

A. O. Mueck and H. Seeger, 2-Methoxyestradiolbiology and mechanism of action, Steroids, vol.75, issue.10, pp.625-631, 2010.

S. P. Mcdermott, A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside, Blood, vol.119, issue.5, pp.1200-1207, 2012.

I. Fares, Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal, Science, vol.345, issue.6203, pp.1509-1512, 2014.

E. Lécuyer, Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction, J Biol Chem, vol.282, issue.46, pp.33649-33658, 2007.

N. Goardon, ETO2 coordinates cellular proliferation and differentiation during erythropoiesis, EMBO J, vol.25, issue.2, pp.357-366, 2006.

M. Carbonaro, A. O'brate, and P. Giannakakou, Microtubule disruption targets HIF-1alpha mRNA to cytoplasmic P-bodies for translational repression, J Cell Biol, vol.192, issue.1, pp.83-99, 2011.

M. S. Poruchynsky, Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins, Proc Natl Acad Sci, vol.112, issue.5, pp.1571-1576, 2015.

R. J. D'amato, C. M. Lin, E. Flynn, J. Folkman, and E. Hamel, 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site, Proc Natl Acad Sci, vol.91, issue.9, pp.3964-3968, 1994.

W. J. Tissing, J. P. Meijerink, M. L. Den-boer, and R. Pieters, Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia, Leukemia, vol.17, issue.1, pp.17-25, 2003.

S. Kusy, 1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia
URL : https://hal.archives-ouvertes.fr/hal-02353654

, J Exp Med, vol.207, issue.10, pp.2141-2156, 2010.

L. Meloty-kapella, B. Shergill, J. Kuon, E. Botvinick, and G. Weinmaster, Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin, Dev Cell, vol.22, issue.6, pp.1299-1312, 2012.

N. Nandagopal and P. P. Roux, Regulation of global and specific mRNA translation by the mTOR signaling pathway, Translation (Austin), vol.3, issue.1, p.983402, 2015.

A. L. Wolfe, RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer, Nature, vol.513, issue.7516, pp.65-70, 2014.

C. G. Palii, Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages, EMBO J, vol.30, issue.3, pp.494-509, 2011.

J. Lacombe, Genetic interaction between Kit and Scl, Blood, vol.122, issue.7, pp.1150-1161, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02353626

T. Sanda, Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia, Cancer Cell, vol.22, issue.2, pp.209-221, 2012.

E. Clappier, Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse, J Exp Med, vol.208, issue.4, pp.653-661, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02353646

J. D. Gordan, C. B. Thompson, and M. C. Simon, HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation, Cancer Cell, vol.12, issue.2, pp.108-113, 2007.

B. J. Shields, R. Alserihi, C. Nasa, C. Bogue, W. S. Alexander et al., Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice, Leukemia, vol.29, issue.4, pp.927-938, 2015.

C. S. Tremblay, T. Hoang, and T. Hoang, Early T cell differentiation lessons from T-cell acute lymphoblastic leukemia, Prog Mol Biol Transl Sci, vol.92, pp.121-156, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00522597

D. Herranz, A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia, Nat Med, vol.20, issue.10, pp.1130-1137, 2014.

Y. Yashiro-ohtani, Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia, Proc Natl Acad Sci U S A, vol.111, issue.46, pp.4946-4953, 2014.

P. J. Real, Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia, Nat Med, vol.15, issue.1, pp.50-58, 2009.

S. Brondfield, Direct and indirect targeting of MYC to treat acute myeloid leukemia, Cancer Chemother Pharmacol, vol.76, issue.1, pp.35-46, 2015.

B. Salvatori, Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2, Genes Cancer, vol.2, issue.5, pp.585-592, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00976767

R. Nasr, Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation, Nat Med, vol.14, issue.12, pp.1333-1342, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00350912

D. Keersmaecker and K. , Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia, Nat Genet, vol.45, issue.2, pp.186-190, 2013.

T. Palomero, Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia, Nat Med, vol.13, issue.10, pp.1203-1210, 2007.

C. V. Dang, MYC on the path to cancer, Cell, vol.149, issue.1, pp.22-35, 2012.

V. Posternak and M. D. Cole, Strategically targeting MYC in cancer, 2016.

J. Lacombe, Scl regulates the quiescence and the long-term competence of hematopoietic stem cells, Blood, vol.115, issue.4, pp.792-803, 2010.

D. Reynaud, SCL/TAL1 expression level regulates human hematopoietic stem cell self-renewal and engraftment, Blood, vol.106, issue.7, pp.2318-2328, 2005.

S. Rojas-sutterlin, E. Lecuyer, and T. Hoang, Kit and Scl regulation of hematopoietic stem cells, Curr Opin Hematol, vol.21, issue.4, pp.256-264, 2014.

G. P. Souroullas, J. M. Salmon, F. Sablitzky, D. J. Curtis, and M. A. Goodell, Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival, Cell Stem Cell, vol.4, issue.2, pp.180-186, 2009.

M. P. Mccormack, Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL, Blood, vol.122, issue.12, pp.2093-2103, 2013.

A. Wilson, c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation, Genes Dev, vol.18, issue.22, pp.2747-2763, 2004.

D. Escuin, The hematopoietic-specific beta1-tubulin is naturally resistant to 2-methoxyestradiol and protects patients from drug-induced myelosuppression, Cell Cycle, vol.8, issue.23, pp.3914-3924, 2009.

L. Hutchinson and R. Kirk, High drug attrition rateswhere are we going wrong?, Nat Rev Clin Oncol, vol.8, issue.4, pp.189-190, 2011.

B. Xia, c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia, Leuk Res, vol.39, issue.1, pp.92-99, 2015.

K. A. Hartwell, Niche-based screening identifies small-molecule inhibitors of leukemia stem cells, Nat Chem Biol, vol.9, issue.12, pp.840-848, 2013.

S. Chattopadhyay, Niche-based screening in multiple myeloma identifies a kinesin-5 inhibitor with improved selectivity over hematopoietic progenitors, Cell Rep, vol.10, issue.4, pp.755-770, 2015.

H. A. Kenny, Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy, Nat Commun, vol.6, p.6220, 2015.

K. Itoh, Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow, Exp Hematol, vol.17, issue.2, pp.145-153, 1989.